mutation predictions | marginal predictions | summary statistics | genome diff | command line log
|
breseq version 0.35.4 revision f352f80f4bc9
mutation predictions | marginal predictions | summary statistics | genome diff | command line log |
| Marginal read alignment evidence (highest frequency 20 of 165 shown, sorted by frequency from high to low) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| seq id | position | ref | new | freq | score (cons/poly) | reads | annotation | genes | product | ||
| * | CP002094 | 2,058,408 | 0 | A | C | 53.8% | 44.6 / 114.8 | 78 | G11G (GGT→GGG) | glmU | bifunctional N‑acetylglucosamine‑1‑phosphate uridyltransferase/glucosamine‑1‑phosphate acetyltransferase |
| * | CP002094 | 515,961 | 0 | G | A | 50.0% | ‑5.5 / 11.2 | 10 | noncoding (1857/2901 nt) | LLNZ_r13413 | 23S ribosomal RNA |
| * | CP002094 | 515,966 | 0 | G | T | 50.0% | ‑5.5 / 12.9 | 10 | noncoding (1862/2901 nt) | LLNZ_r13413 | 23S ribosomal RNA |
| * | CP002094 | 515,967 | 0 | T | G | 50.0% | ‑5.5 / 14.9 | 10 | noncoding (1863/2901 nt) | LLNZ_r13413 | 23S ribosomal RNA |
| * | CP002094 | 515,989 | 0 | A | C | 50.0% | ‑5.2 / 16.2 | 12 | noncoding (1885/2901 nt) | LLNZ_r13413 | 23S ribosomal RNA |
| * | CP002094 | 1,904,623 | 0 | C | A | 45.6% | 75.8 / 58.0 | 79 | L162F (TTG→TTT) | LLNZ_09895 | exodeoxyribonuclease V alpha chain |
| * | CP002094 | 515,974 | 0 | A | . | 45.5% | ‑5.2 / 16.8 | 11 | noncoding (1870/2901 nt) | LLNZ_r13413 | 23S ribosomal RNA |
| * | CP002094 | 515,979 | 0 | A | C | 45.5% | ‑5.1 / 15.9 | 11 | noncoding (1875/2901 nt) | LLNZ_r13413 | 23S ribosomal RNA |
| * | CP002094 | 515,981 | 0 | T | G | 45.5% | ‑5.1 / 15.6 | 11 | noncoding (1877/2901 nt) | LLNZ_r13413 | 23S ribosomal RNA |
| * | CP002094 | 1,702,568 | 0 | T | G | 44.4% | 51.1 / 20.9 | 63 | intergenic (‑247/+8) | rpsA/mnmA | 30S ribosomal protein S1/tRNA‑specific 2‑thiouridylase MnmA |
| * | CP002094 | 1,590,855 | 0 | A | C | 42.2% | 99.6 / 78.8 | 90 | G701G (GGT→GGG) | LLNZ_08320 | hypothetical protein |
| * | CP002094 | 1,004,360 | 0 | T | G | 42.1% | 85.6 / 36.9 | 77 | G22G (GGT→GGG) | trpA | tryptophan synthase subunit alpha |
| * | CP002094 | 515,987 | 0 | G | C | 41.7% | ‑4.7 / 14.5 | 12 | noncoding (1883/2901 nt) | LLNZ_r13413 | 23S ribosomal RNA |
| * | CP002094 | 515,990 | 0 | T | A | 41.7% | ‑4.7 / 13.8 | 12 | noncoding (1886/2901 nt) | LLNZ_r13413 | 23S ribosomal RNA |
| * | CP002094 | 1,203,499 | 0 | T | C | 41.1% | 68.4 / 28.6 | 57 | E169G (GAA→GGA) | LLNZ_06335 | hypothetical protein |
| * | CP002094 | 199,845 | 0 | T | G | 40.2% | 126.6 / 38.3 | 82 | G109G (GGT→GGG) | LLNZ_01100 | rhamnosyltransferase |
| * | CP002094 | 515,976 | 0 | G | . | 40.0% | ‑5.2 / 12.5 | 11 | noncoding (1872/2901 nt) | LLNZ_r13413 | 23S ribosomal RNA |
| * | CP002094 | 1,097,000 | 0 | A | G | 39.0% | 100.7 / 41.2 | 82 | G207G (GGA→GGG) | LLNZ_05840 | 2‑dehydropantoate 2‑reductase |
| * | CP002094 | 500,260 | 0 | G | C | 38.9% | 79.7 / 27.3 | 54 | Q121E (CAA→GAA) | LLNZ_02620 | peptide binding protein |
| * | CP002094 | 1,013,686 | 0 | T | G | 38.0% | 140.0 / 50.6 | 94 | G216G (GGT→GGG) | LLNZ_05425 | glycine betaine‑binding periplasmic protein precursor |
| Marginal new junction evidence (sorted from low to high skew) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| seq id | position | reads (cov) | reads (cov) | score | skew | freq | annotation | gene | product | ||
| * | ? | CP002094 | = 2131338 | NA (NA) | 9 (0.120) +25 bp |
7/146 | 9.2 | NA | noncoding (7/73 nt) | LLNZ_t13347 | tRNA‑Thr |
| ? | CP002094 | 2131656 = | NA (NA) | noncoding (58/73 nt) | LLNZ_t13355 | tRNA‑Val | |||||
| * | ? | CP002094 | = 1321880 | 56 (0.560) | 4 (0.050) | 4/148 | 11.2 | 7.8% | intergenic (‑192/+485) | LLNZ_06960/LLNZ_06965 | xanthine phosphoribosyltransferase/hypothetical protein |
| ? | CP002094 | 1381355 = | 53 (0.710) | intergenic (‑458/+78) | LLNZ_07275/LLNZ_07280 | hypothetical protein/guanosine 5'‑monophosphate oxidoreductase | |||||
| * | ? | CP002094 | = 518215 | 104 (1.040) | 9 (0.090) +TA |
7/192 | 11.4 | 7.4% | intergenic (+2/‑9) | LLNZ_t13313/LLNZ_t13315 | tRNA‑Phe/tRNA‑Gly |
| ? | CP002094 | = 2500912 | 127 (1.270) | intergenic (‑1/+35) | LLNZ_t13375/LLNZ_t13377 | tRNA‑Tyr/tRNA‑Val | |||||
| * | ? | CP002094 | = 25978 | 132 (1.320) | 9 (0.090) +TA |
7/192 | 11.4 | 6.6% | intergenic (+2/‑10) | LLNZ_t13263/LLNZ_t13265 | tRNA‑Phe/tRNA‑Gly |
| ? | CP002094 | = 2500912 | 127 (1.270) | intergenic (‑1/+35) | LLNZ_t13375/LLNZ_t13377 | tRNA‑Tyr/tRNA‑Val | |||||
| * | ? | CP002094 | 592381 = | 106 (1.060) | 3 (0.040) +23 bp |
3/150 | 12.1 | 3.6% | noncoding (5/76 nt) | LLNZ_t13323 | tRNA‑Lys |
| ? | CP002094 | 2131656 = | NA (NA) | noncoding (58/73 nt) | LLNZ_t13355 | tRNA‑Val | |||||
| * | ? | CP002094 | 2498042 = | 131 (1.310) | 3 (0.030) | 3/188 | 13.9 | 2.6% | coding (484/528 nt) | LLNZ_13130 | transcriptional regulator |
| ? | CP002094 | 2498362 = | 97 (1.020) | coding (164/528 nt) | LLNZ_13130 | transcriptional regulator | |||||